Arkolith/Insider Trading/GYRE/Form 4

Ma Songjiang

President, DirectorGYRE THERAPEUTICS, INC. (GYRE) · full profile →Form 4 · filed May 29, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$26K
Net Open-Market Flow
-$26K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 28, 2025Sell(S)558$10.07$6K2.8M
May 27, 2025Sell(S)2K$10.28$21K2.8M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001140361-25-020754) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML